>
Switch to:

Keros Therapeutics PS Ratio

: 486.86 (As of Today)
View and export this data going back to 2020. Start your Free Trial

As of today, Keros Therapeutics's share price is $66.700000. Keros Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2020 was $0.14. Hence, Keros Therapeutics's P/S Ratio for today is 486.86.

Good Sign:

Keros Therapeutics Inc stock PS Ratio (=68.52) is close to 1-year low of 64.69

NAS:KROS' s PS Ratio Range Over the Past 10 Years
Min: 64.69   Med: 331.42   Max: 590.95
Current: 492.7

64.69
590.95

During the past 2 years, Keros Therapeutics's highest P/S Ratio was 590.95. The lowest was 64.69. And the median was 331.42.

NAS:KROS's PS Ratio is ranked lower than
89% of the 927 Companies
in the Biotechnology industry.

( Industry Median: 21.76 vs. NAS:KROS: 492.70 )

Keros Therapeutics's Revenue per Sharefor the three months ended in Sep. 2020 was $0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2020 was $0.14.

During the past 12 months, the average Revenue per Share Growth Rate of Keros Therapeutics was -83.70% per year.

Back to Basics: P/S Ratio


Keros Therapeutics PS Ratio Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Keros Therapeutics Annual Data
Dec18 Dec19
PS Ratio 0.00 0.00

Keros Therapeutics Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
PS Ratio Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Keros Therapeutics PS Ratio Distribution

* The bar in red indicates where Keros Therapeutics's PS Ratio falls into.



Keros Therapeutics PS Ratio Calculation

The P/S Ratio is another ratio widely used to value stocks. It was first used by Ken Fisher.

Keros Therapeutics's P/S Ratio for today is calculated as

P/S Ratio=Share Price/Revenue per Share (TTM)
=66.700000/0.137
=486.86

Keros Therapeutics's Share Price of today is $66.700000.
Keros Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2020 was 0.137 (Dec. 2019 ) + 0 (Mar. 2020 ) + 0 (Jun. 2020 ) + 0 (Sep. 2020 ) = $0.14.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

It can also be calculated from the numbers for the whole company:

P/E Ratio=Market Cap/Revenue

The revenue here is for the trailing 12 months.


Keros Therapeutics  (NAS:KROS) PS Ratio Explanation

The P/S ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The P/S ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The P/S ratio is a great valuation tool for evaluating cyclical businesses where the P/E ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the P/S ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the Price/Earnings ratio and Price/Cash Flow or Price/Free Cash Flow, the P/E ratio measures the valuation based on the earning power of the company. This is where it is different from Price/Book ratio, which measures the valuation based on the company's balance sheet.


Be Aware

The P/S ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Keros Therapeutics PS Ratio Related Terms


Keros Therapeutics PS Ratio Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)